Quantitative analysis of PKP2 and neighbouring genes in a patient with arrhythmogenic right ventricular cardiomyopathy caused by heterozygous PKP2 deletion

被引:11
|
作者
Sonoda, Keiko [1 ,2 ]
Ohno, Seiko [2 ,3 ,4 ]
Otuki, Sou [1 ]
Kato, Koichi [2 ]
Yagihara, Nobue [1 ]
Watanabe, Hiroshi [1 ]
Makiyama, Takeru [4 ]
Minamino, Tohru [1 ]
Horie, Minoru [2 ]
机构
[1] Niigata Univ, Dept Cardiovasc Biol & Med, Grad Sch Med & Dent Sci, Niigata, Japan
[2] Shiga Univ Med Sci, Dept Cardiovasc & Resp Med, Tsukiwa Cho, Otsu, Shiga 5202192, Japan
[3] Shiga Univ Med Sci, Ctr Epidemiol Res Asia, Otsu, Shiga, Japan
[4] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan
来源
EUROPACE | 2017年 / 19卷 / 04期
关键词
Arrhythmogenic right ventricular cardiomyopathy; Gene; Mutation; Screening; Plakophilin; PKP2; deletion; DEPENDENT PROBE AMPLIFICATION; IDENTIFICATION; MUTATIONS; SPECTRUM; IMPACT;
D O I
10.1093/europace/euw038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a disease mainly caused by desmosome gene mutations. The genetic culprit, however, remains elusive in similar to 50% of ARVC patients. One of the reasons for missing genetic abnormalities is the difficulty in detecting large deletions/duplications, which are called as copy number variation (CNV) by the Sanger sequencing method. This study aimed to identify CNVs in PKP2 and a part of other desmosome genes in ARVC patients. The study cohort consisted of 71 ARVC probands who were diagnosed as definite or borderline cases based on 2010 Task Force Criteria. Among them, 32 (45%) carried at least one mutation in desmosome genes detected by the Sanger method. Using the multiplex ligation-dependent probe amplification method, we identified a male proband (1.4%) with a complete deletion of all PKP2 coding exons. He was 31 years old and showed exercise-induced sustained ventricular tachycardia with superior axis and left bundle-branch block pattern. His cardiac magnetic resonance imaging and computed tomography showed right ventricular dilatation and reduced ejection fraction. His 12-lead electrocardiogram showed T-wave inversion in V1-V3, and late potentials were positive, indicating definite ARVC. To confirm the precise location of the deletion, we performed relative quantitative PCR. We found complete deletion of both SYT10 and ALG10 located in 3' of PKP2; the total deletion size was at least 1.23 Mb. Screening for CNVs in desmosome genes is useful to identify the genetic basis of disease in clinically suspected ARVC patients.
引用
收藏
页码:644 / 650
页数:7
相关论文
共 50 条
  • [31] PKP2 Mutations in Sudden Death From Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) and Sudden Unexpected Death With Negative Autopsy (SUDNA)
    Zhang, Mingchang
    Tavora, Fabio
    Oliveira, Joao Bosco
    Li, Ling
    Franco, Marcello
    Fowler, David
    Zhao, Ziqin
    Burke, Allen
    CIRCULATION JOURNAL, 2012, 76 (01) : 189 - 194
  • [32] Establishment of an arrhythmogenic right ventricular cardiomyopathy derived iPSC cell line (USFi004-A) carrying a heterozygous mutation in PKP2 (c.1799delA)
    Yang, Jiajia
    Samal, Eva
    Angulo, Mariana Burgos
    Bertalovitz, Alexander
    McDonald, Thomas, V
    STEM CELL RESEARCH, 2021, 54
  • [33] Epicardial Ventricular Tachycardia Ablation in a Patient With Brugada ECG Pattern and Mutation of PKP2 and DSP Genes
    Forkmann, Mathias
    Tomala, Jakub
    Huo, Yan
    Mayer, Julia
    Christoph, Marian
    Wunderlich, Carsten
    Salmas, Jozef
    Gaspar, Thomas
    Piorkowski, Christopher
    Circulation-Arrhythmia and Electrophysiology, 2015, 8 (02): : 505 - 507
  • [34] Homozygous PKP2 deletion associated with neonatal left ventricle noncompaction
    Ramond, F.
    Janin, A.
    Di Filippo, S.
    Chanavat, V.
    Chalabreysse, L.
    Roux-Buisson, N.
    Sanlaville, D.
    Touraine, R.
    Millat, G.
    CLINICAL GENETICS, 2017, 91 (01) : 126 - 130
  • [35] Cardiac AAV:PKP2 Gene Therapy Reduces Ventricular Arrhythmias, Reverses Adverse Right Ventricular Remodeling, Improves Heart Function, and Extends Survival in a Pkp2-Deficient Mouse Model of Arrhythmogenic Right Ventricular Cardiomyopathy
    Yang, Zhihong Jane
    Wu, Iris
    Greer-Short, Amara
    Zeng, Aliya
    Xu, Emma
    Van Pell, Melissa
    Aycinena, Alex
    Rodriguez, Neshel
    Lim, Beatriz
    Chung, Tae Won
    Ho, Jaclyn
    Steltzer, Stephanie
    Butler, Renee
    Lin, JianMin
    Priest, James
    Jing, Frank
    Green, Kristina
    Ivey, Kathy
    Hoey, Tim
    Yang, Jin
    MOLECULAR THERAPY, 2022, 30 (04) : 297 - 297
  • [36] Arrhythmogenic cardiomyopathy phenotype associated with the pathogenic founder variant c.1211dup in PKP2
    Bos, T. A.
    Piers, S. R. D.
    Wessels, M. W.
    Houweling, A. C.
    Hoedemakers, Y. M.
    Bosman, L. P.
    Riele, A. S. J. M. Te
    Koopmann, T. T.
    Van Tintelen, J. P.
    Barge-Schaapveld, D. Q. C. M.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [37] A CASE REPORT: PKP2 GENE C.1592T>G VARIATION IN HOMOZYGOUS FORM IDENTIFIED IN ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA PATIENT
    Bidina, Luize
    Kupics, Kaspars
    Sokolova, Emma
    Pavlovics, Mihails
    Dobele, Zane
    Piekuse, Linda
    Kalejs, Oskars
    CBU INTERNATIONAL CONFERENCE PROCEEDINGS 2016: INNOVATIONS IN SCIENCE AND EDUCATION, 2016, 4 : 631 - 633
  • [38] Clinical and Molecular Data Define a Diagnosis of Arrhythmogenic Cardiomyopathy in a Carrier of a Brugada-Syndrome-Associated PKP2 Mutation
    Persampieri, Simone
    Pilato, Chiara Assunta
    Sommariva, Elena
    Maione, Angela Serena
    Stadiotti, Ilaria
    Ranalletta, Antonio
    Torchio, Margherita
    Dello Russo, Antonio
    Basso, Cristina
    Pompilio, Giulio
    Tondo, Claudio
    Casella, Michela
    GENES, 2020, 11 (05)
  • [39] Molecular disturbance underlies to arrhythmogenic cardiomyopathy induced by transgene content, age and exercise in a truncated PKP2 mouse model
    Moncayo-Arlandi, Javier
    Guasch, Eduard
    Sanz-de la Garza, Maria
    Casado, Marta
    Aquiles Garcia, Nahuel
    Mont, Lluis
    Sitges, Marta
    Knoll, Ralph
    Buyandelger, Byambajav
    Campuzano, Oscar
    Diez-Juan, Antonio
    Brugada, Ramon
    HUMAN MOLECULAR GENETICS, 2016, 25 (17) : 3676 - 3688
  • [40] LX2020-An AAV Based Gene Therapy Improves the Arrhythmogenic Right Ventricular Cardiomyopathy Phenotype in a Severe Mouse Model Harboring Human PKP2 Mutation
    Sheikh, Farah
    Zhang, Jing
    Nair, Anju
    Do, Aryanne
    Nguyen, Lena
    Lara, Erika Gutierrez
    Fargnoli, Anthony S.
    Wang, Jie
    Bradford, William H.
    Granados, Sonia Gutierrez
    Law, Ken
    Fenn, Tim
    McCormac, Paul
    Selvan, Nithya
    Khanna, Richie
    MOLECULAR THERAPY, 2023, 31 (04) : 110 - 111